5-Amino-1MQ (5-amino-1-methylquinolinium)
Small-molecule NNMT inhibitor studied in mice and cells for diet-induced obesity and age-related muscle decline.
What it is
Blocks nicotinamide N-methyltransferase (NNMT), an enzyme linked to cell metabolism and energy balance. In cultured fat cells, it reduced fat formation and raised NAD+ and SAM levels at some concentrations; these are laboratory findings.
What it is studied for
Researchers have tested it in obese mice fed a high-fat diet and in aged mice. One study measured muscle repair after injury in 24-month-old mice; another compared it with and without intensive exercise in older mice.
What the evidence says
Animal and cell studies only
In an 11-day study of 9 obese mice per group, treated mice lost about 5% of body weight while controls gained slightly, with no change in food intake. Aged mice showed better muscle regeneration and grip strength. None of these results come from people. The three cited studies share authors; three 2024 authors declared roles at Ridgeline Therapeutics.
How it was studied
The mouse studies gave 5-amino-1MQ by injection under the skin. Dissolving strips, alone or combined with NAD+ and MOTS-c, were not the form studied.
Where to find it
Lean Energy
- Dissolving strips NAD+ 80 mg, MOTS-c 2 mg and 5-Amino-1MQ 2 mg per strip, 30 strips
Sold by USA Standard Research, the team behind PeptidesGenie, for research use only. Not for human or veterinary use.
Sources
- 1PubChem: 5-Amino-1-methylquinolinium, CID 950107 Chemical reference
- 2
- 3
- 4
Source-checked · 27 Oct 2026